博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司提升原料血浆供应能力

智通财经2025-05-30

智通财经APP讯，博雅生物(300294.SZ)发布公告，为提升原料血浆供应能力，增强市场竞争力，深化与关联方的战略合作，公司拟与关联方成都恒纳顺企业管理咨询有限责任公司(以下简称成都恒纳顺)共同出资设立达拉特旗博雅单采血浆有限公司(最终名称以工商登记为准，以下简称标的公司)。成都恒纳顺由深圳市高特佳润华投资有限公司(以下简称高特佳润华)出资120万元，占比60%;胡国彬出资80万元，占比40%...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2539178229?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-30 19:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539178229","market":"hk","top_or_hot":-1,"title":"博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司 提升原料血浆供应能力","media":"智通财经","content":"<div>\n<p>智通财经APP讯，博雅生物(300294.SZ)发布公告，为提升原料血浆供应能力，增强市场竞争力，深化与关联方的战略合作，公司拟与关联方成都恒纳顺企业管理咨询有限责任公司(以下简称成都恒纳顺)共同出资设立达拉特旗博雅单采血浆有限公司(最终名称以工商登记为准，以下简称标的公司)。成都恒纳顺由深圳市高特佳润华投资有限公司(以下简称高特佳润华)出资120万元，占比60%;胡国彬出资80万元，占比40%...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1299805.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司 提升原料血浆供应能力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司 提升原料血浆供应能力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-30 19:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1299805.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，博雅生物(300294.SZ)发布公告，为提升原料血浆供应能力，增强市场竞争力，深化与关联方的战略合作，公司拟与关联方成都恒纳顺企业管理咨询有限责任公司(以下简称成都恒纳顺)共同出资设立达拉特旗博雅单采血浆有限公司(最终名称以工商登记为准，以下简称标的公司)。成都恒纳顺由深圳市高特佳润华投资有限公司(以下简称高特佳润华)出资120万元，占比60%;胡国彬出资80万元，占比40%...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1299805.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1299805.html","article_id":"2539178229","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539178229","pubTimestamp":1748603375,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，博雅生物 发布公告，为提升原料血浆供应能力，增强市场竞争力，深化与关联方的战略合作，公司拟与关联方成都恒纳顺企业管理咨询有限责任公司共同出资设立达拉特旗博雅单采血浆有限公司。深圳市高特佳投资集团有限公司控股高特佳润华，间接控股成都恒纳顺。高特佳集团持有公司11.31%股份，故成都恒纳顺为公司关联方。此次与关联方共同投资设立公司，开启了公司与高特佳集团合作的重要里程碑。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300294":"博雅生物","BK0046":"生物疫苗","BK0239":"医药制造","BK0197":"中小创蓝筹"},"translate_title":"Boya Biotech (300294. SZ) plans to jointly invest with Chengdu Hengnashun to establish a company to improve the supply capacity of raw plasma","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300294":1},"content_text":"智通财经APP讯，博雅生物(300294.SZ)发布公告，为提升原料血浆供应能力，增强市场竞争力，深化与关联方的战略合作，公司拟与关联方成都恒纳顺企业管理咨询有限责任公司(以下简称成都恒纳顺)共同出资设立达拉特旗博雅单采血浆有限公司(最终名称以工商登记为准，以下简称标的公司)。成都恒纳顺由深圳市高特佳润华投资有限公司(以下简称高特佳润华)出资120万元，占比60%;胡国彬出资80万元，占比40%组成。深圳市高特佳投资集团有限公司(以下简称高特佳集团)控股高特佳润华，间接控股成都恒纳顺。高特佳集团持有公司11.31%股份，故成都恒纳顺为公司关联方。此次与关联方共同投资设立公司，开启了公司与高特佳集团合作的重要里程碑。通过整合双方资源，未来双方将在单采血浆业务及相关领域进一步深入合作，充分发挥各自优势，实现互利共赢，为公司在血液制品市场的长远发展奠定坚实基础。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2539178229","isCrawlerRequest":true}

博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司 提升原料血浆供应能力

精彩评论

博雅生物(300294.SZ)拟与成都恒纳顺共同投资设立公司提升原料血浆供应能力